Search clinical trials for: High risk

Total 30688 results

Elsan

Recruiting

Rotator Cuff Repair Under Isolated Loco-regional Anesthesia (AGORA)

Shoulder Cuff Surgical Repair

France
Stanford University

Not yet recruiting

Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide

Suicide and Self-harm

United States
Technische Universität Dresden
German Cancer Research Center; KKS Dresden

Not yet recruiting

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula (XandTX)

Periampullary Cancer | Postoperative Pancreatic Fistula

Germany
The Mind Research Network

Recruiting

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Criminal Behavior | Stimulant Abuse

United States
University of California, Davis
National Cancer Institute (NCI); IO Biotech

Recruiting

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

United States
Institute of Hematology & Blood Diseases Hospital

Recruiting

BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT

Multiple Myeloma

China
Oslo University Hospital
Targovax ASA

Recruiting

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Multiple Myeloma | Smoldering Multiple Myeloma

Norway
Fudan University

Recruiting

The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma (IRIS)

High-Risk Localized Soft Tissue Sarcoma

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies.

Myeloid Malignancy | Venetoclax | Hypomethylating Agent

China
University of Alabama at Birmingham

Not yet recruiting

Improving the Cardiovascular Health of High-Risk Families Through an Innovative Home Visitation Intervention

Health Behavior | Maternal Behavior | Nutrition, Healthy

United States
University of Liverpool
Liverpool Women's NHS Foundation Trust

Recruiting

Can Cervical Stiffness in the Second Trimester Predict Preterm Birth in High-Risk Singleton Pregnancies? (PRECISION)

Preterm Birth

United Kingdom
Tianjin Medical University Second Hospital

Recruiting

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)

Neoadjuvant Immunotherapy

China
Tel-Aviv Sourasky Medical Center
Dana-Farber Cancer Institute

Recruiting

Predicting Progression of Developing Myeloma in a High-Risk Screened Population

Healthy

Israel
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Pyrotinib in Women With High-risk in Early Stage Breast Cancer

HER2-positive Breast Cancer

China
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and other collaborators

Recruiting

Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients. (DAN-PTRAII)

Heart Failure | Percutaneous Transluminal Angioplasty | Renovascular Hypertension | Renal Artery Stenosis Atherosclerotic | Renovascular Hypertension With Renal Failure

Denmark
Peking University People's Hospital
Peking University Cancer Hospital & Institute

Recruiting

Frontline of ASCT in High-risk DLBCL (Essential)

Diffuse Large B Cell Lymphoma

China
PureTech

Recruiting

A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)

MDS | AML, Adult Recurrent

United States
Leiden University Medical Center

Recruiting

Elucidating the High Cardiovascular Disease Risk in South Asians (CAMI)

Cardiovascular Diseases

Netherlands
Medical University of Vienna

Recruiting

Metacognitive Training in Ultra-high Risk

Clinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental State

Austria
Research Foundation for Mental Hygiene, Inc.
Columbia University

Not yet recruiting

Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2

Stigma, Social | Help-Seeking Behavior

United States
Genesis Research LLC

Recruiting

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

Prostate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen

United States
Institut Claudius Regaud
Bayer

Recruiting

SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer (SUGAR)

Prostate Cancer

France
Qilu Pharmaceutical (Hainan) Co., Ltd.

Not yet recruiting

A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.

PONV
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health (PROACT 1)

Coronary Artery Disease

United States
Abiomed Inc.

Recruiting

Impella Real-World Surveillance of Patients Using Sodium Bicarbonate

Cardiogenic Shock | High Risk PCI

United States
The First Affiliated Hospital with Nanjing Medical...
Jiangbin Hospital Affiliated to Jiangsu University; Nanjing Second Hospital; Jiangning...

Recruiting

Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN

MDS/MPN

China
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT

Conditioning | Haploidentical Stem Cell Transplantation

China
Centre Hospitalier Universitaire Dijon

Recruiting

Randomized Controlled Pilot Study of Methods for Identifying Patients at High Risk of Worsening in the Adult Emergency Department (Quick-TRI)

Non-traumatic Medical Emergency

France
Heinrich-Heine University, Duesseldorf

Recruiting

Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders (CARE)

Psychotic Disorders | Prevention

Germany
IRCCS San Raffaele

Recruiting

Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases

Rheumatic Diseases | Pregnancy Complications | Pregnancy, High Risk | Fertility Disorders | Immunologic Disease

Italy
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Prostate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8

United States
Geisinger Clinic

Recruiting

Low Dose Aspirin Alerts in High-Risk Pregnancies

Aspirin | Preeclampsia | Clinical Decision Support Systems | Economics, Behavioral

United States
Eli Lilly and Company

Recruiting

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

Cardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or Obesity

United States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Premenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or Torimefen

China
Jennifer Crombie, MD
Genentech, Inc.

Recruiting

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

Lymphoma | Lymphoma, Large B-Cell, Diffuse

United States
MidLantic Urology
Blue Earth Diagnostics

Not yet recruiting

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

Prostate Cancer

United States
Samsung Medical Center

Recruiting

Invasive Versus Non-invasive Approach in Symptomatic Patient With Non-High Risk Coronary Artery Stenosis (SMART-STEP)

Coronary Artery Disease

Korea, Republic of
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression (IMAGINATION)

Primary IgA Nephropathy

Korea, Republic of, Australia, Spain, United Kingdom, China, France, Taiwan, United States, Italy, Greece, Czechia, Singapore, Japan, Argentina, Germany, Brazil, Poland
Sultan Qaboos University
Ministry of Higher Education, Research and Innovation

Not yet recruiting

The Impact of Using a Smartphone Health Application in the Improvement of Cardiovascular Disease Risk Factors

Hypertension | Obesity | Diabetes Mellitus | Hypercholesterolemia
Samsung Medical Center

Not yet recruiting

Routine Versus As-Needed Stress Testing in Asymptomatic Patients With High-Risk Coronary Calcium (SMART-EXAM)

Coronary Atherosclerosis Due to Calcified Coronary Lesion
Bayer

Recruiting

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP)

Biochemically Recurrent Prostate Cancer

Austria, Spain, United States, Australia, Brazil, France, Germany, Taiwan, Denmark, China, Netherlands, Portugal, Japan, Canada, Finland, Italy, Hungary, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
Stanford University
Kite Pharma

Recruiting

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

Non-Hodgkin Lymphoma | Large B-cell Lymphoma

United States
Washington University School of Medicine

Recruiting

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) (Patch BRIDGE)

Pregnancy Complications | Pregnancy Related | Pregnancy, High Risk | Opioid Use Disorder | Buprenorphine Withdrawal

United States
IRCCS San Raffaele

Recruiting

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

Rheumatic Diseases | Pregnancy Complications | Pregnancy, High Risk | Preeclampsia | Immunologic Disease | Antiphospholipid Antibody Syndrome Primary

Italy
University Health Network, Toronto

Not yet recruiting

Short Antibiotic Treatment in High Risk Febrile Neutropenia

Febrile Neutropenia
Novatek Pharmaceuticals

Recruiting

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. (BOSS-002)

COVID-19

United States
Wuhan Union Hospital, China
Peking University First Hospital

Recruiting

High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

Cardiovascular Diseases | Coronary Disease | Diabetes Mellitus, Type 2

China
University of Southern California
California Physical Therapy Association; Cerebral Palsy Foundation

Recruiting

Feasibility of an In-home Standing and Walking Intervention for Infants With and at High Risk of Cerebral Palsy

Cerebral Palsy

United States
University of Malaya
University of Hawaii Cancer Research Center; University of Guam

Not yet recruiting

Adapting a Betel Quid Cessation Program for a High-risk Community in Malaysia and Evaluating Its Effectiveness (M-BENIT)

Tobacco Cessation | Betel Nut Chewer

Malaysia
Groupe Francophone des Myelodysplasies
Bristol-Myers Squibb; AbbVie

Recruiting

Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes

Untreated Myelodysplastic Syndrome

France

Search clinical trials for: High risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations